Caribou Cash And Short Term Investments from 2010 to 2024
| CRBU Stock | USD 2.19 0.01 0.45% |
Cash And Short Term Investments | First Reported 2010-12-31 | Previous Quarter 328.8 M | Current Value 247.5 M | Quarterly Volatility 132.4 M |
Check Caribou Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caribou Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 202.7 K, Net Interest Income of 119.7 K or Interest Income of 126.5 K, as well as many indicators such as Price To Sales Ratio of 11.65, Dividend Yield of 0.0 or PTB Ratio of 1.09. Caribou financial statements analysis is a perfect complement when working with Caribou Biosciences Valuation or Volatility modules.
Caribou | Cash And Short Term Investments |
Latest Caribou Biosciences' Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Caribou Biosciences over the last few years. Short Term Investments is an account in the current assets section of Caribou Biosciences balance sheet. This account contains Caribou Biosciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Caribou Biosciences fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Caribou Biosciences' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caribou Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Caribou Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 121,165,927 | |
| Geometric Mean | 75,560,302 | |
| Coefficient Of Variation | 109.26 | |
| Mean Deviation | 109,621,626 | |
| Median | 49,471,000 | |
| Standard Deviation | 132,388,062 | |
| Sample Variance | 17526.6T | |
| Range | 397.6M | |
| R-Value | 0.69 | |
| Mean Square Error | 9774.5T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 20,555,151 | |
| Total Sum of Squares | 245372.4T |
Caribou Cash And Short Term Investments History
About Caribou Biosciences Financial Statements
Caribou Biosciences shareholders use historical fundamental indicators, such as Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Caribou Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Caribou Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Caribou Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 328.8 M | 247.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Caribou Stock Analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.